NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
25 avr. 2024 08h35 HE
|
NurExone Biologic Inc
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
Solar Alliance first quarter corporate update shows continued growth for commercial solar
15 avr. 2024 07h59 HE
|
Solar Alliance Energy Inc.
TORONTO and KNOXVILLE, Tenn., April 15, 2024 (GLOBE NEWSWIRE) -- Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR), a leading solar energy solutions provider focused on...
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
01 avr. 2024 07h35 HE
|
GRI Bio, Inc.
Ongoing Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) with interim data expected H1 2024 and topline data expected H2 2024 ...
Gross Proceeds Close of $4M CAD Generated for NurExone From Warrants Exercise
27 mars 2024 17h05 HE
|
NurExone Biologic Inc
Gross Proceeds close of $4M CAD Generated for NurExone from Warrants Exercise
Odysight.ai Announces 2023 Financial Results and Provides Corporate Update
27 mars 2024 08h30 HE
|
Odysight.ai Inc.
Revenues increased in more than 350% from its commercial contracts OMER, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive...
Sacks Parente Golf, Inc. Announces Year End 2023 Financial Results and Provides Corporate Update
18 mars 2024 08h00 HE
|
Sacks Parente Golf, Inc.
Camarillo, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Sacks Parente Golf, Inc. (NASDAQ:SPGC), (the “Company” or “Sacks Parente”), a technology-forward golf company with a growing portfolio of golf...
Revive Therapeutics Provides Corporate Update
12 mars 2024 07h00 HE
|
Revive Therapeutics Ltd.
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
Premier Products Group Issues Shareholder Letter
28 févr. 2024 16h29 HE
|
Premier Products Group, Inc.
BREMERTON, Wash., Feb. 28, 2024 (GLOBE NEWSWIRE) -- via IBN -- Premier Products Group, Inc. (OTC: PMPG) today issued a letter to shareholders from Terry L Stein, Interim CEO. Dear shareholders, We...
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
08 févr. 2024 15h30 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Abaxx Provides Q1 Corporate Update
01 févr. 2024 07h00 HE
|
Abaxx Technologies Inc.
TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of...